Galaxy Biotech

Galaxy Biotech is a pharmaceutical biotechnology company. The company's initial plan was to develop a monoclonal antibody (MAb) against hepatocyte growth factor (HGF), a growth factor considered to play a significant role in the growth and angiogenesis of many tumors. Recently, the company has developed novel monoclonal antibodies against fibroblast growth factor 2 (FGF 2) and FGF receptor 2 (FGFR 2).